New Zealand : Healthcare, Regulatory and Reimbursement Landscape Insight

Request For Sample Report- https://www.marketresearchhub.com/enquiry.php?type=S&repid=1787319

New Zealand is a mature healthcare market, with a strong regulatory environment. It spends approximately 11% of its GDP on healthcare. In 2015 pharmaceutical sales declined to $688.7m from $796.0m in 2014. This rose to $746.3m in 2016. The market is forecast to grow to $1.03 billion in 2022; at a CAGR of 6%. In 2010, the medical device market in New Zealand was worth $1.17 billion, which increased to $1.48 billion in 2017. The main segments were ophthalmic devices, wound care management, healthcare IT, orthopedic devices and in vitro diagnostics. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market. However, high penetration of generics in the market and the policies of PHARMAC, pose as a barrier for the multinational pharmaceutical manufacturers.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
– Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
– Porters five forces analysis for pharmaceutical and medical devices market of New Zealand
– An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
– Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
– An overview of the opportunities for and challenges to growth in the New Zealand healthcare market.

Browse Full Report with TOC- https://www.marketresearchhub.com/report/countryfocus-healthcare-regulatory-and-reimbursement-landscape-new-zealand-report.html

Reasons to buy

This report will enhance your decision-making capability by allowing you to –
– Develop business strategies by understanding the trends shaping and driving the New Zealand healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
– Identify, understand, and capitalize on the opportunities and challenges in the New Zealand healthcare market.